Structure-binding relationship of quinuclidinyl benzilate analogs on N4TG1 neuroblastoma muscarinic receptors.
By Scatchard plot analysis of [3H]QNB (quinuclidinyl benzilate) binding, there are 2 x 10(5) muscarinic sites/cell with a KD about 10 nM in N4TG1 neuroblastoma cells. We have now examined a group of compounds structurally related to aprophen and QNB for their ability to compete with the binding of QNB to the muscarini receptor. Using this structure-inhibition relationship, the functional groups of the muscarinic ligand necessary for binding were partially characterized. It was found that the quinuclidinyl ring structure of QNB can be substituted by either alkane, H, or pyrrolidine at the N without loosing their ability to bind. The addition to the quinuclidinyl ring increases the bulk of the structure and decreases binding. Like the benzilate in QNB, a similar hydrophobic structure is apparently required for the binding.
Chang
Y F
YF
Department of Biochemistry, University of Maryland Dental School, Baltimore 21201.
D009447:Neuroblastoma / Q000378:metabolism*; D011812:Quinuclidines; D011813:Quinuclidinyl Benzilate / Q000031:analogs & derivatives*; D011976:Receptors, Muscarinic / Q000378:metabolism*; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured
D011812:Quinuclidines; D011976:Receptors, Muscarinic; D011813:Quinuclidinyl Benzilate